Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, and Blood Cancer United® (formerly The Leukemia & Lymphoma Society), the largest global ...
A new treatment for advanced skin cancer has been released. Melanoma is a dangerous type of skin cancer that presents as unusual moles, sores and lumps. New therapeutic advances for metastatic ...
The very first patient would receive the first clinical doses of HMBD-001, the first cancer treatment from Hummingbird Bioscience. Piers Ingram, the cofounder and CEO of the company, was nervous, but ...
SurvivorNet on MSN
As more people turn to AI for healthcare answers, cancer patients get a doctor-supported source they can trust
SurvivorNet's AI-Powered Tool “My Health Questions” Helps Patients Navigate Cancer With Confidence.
HORSHAM, Pa., Feb. 2, 2026 /PRNewswire/ -- Johnson & Johnson today announced new real world head-to-head evidence demonstrating that patients with metastatic castration-sensitive prostate cancer ...
The Queen Zone on MSN
Clinical trials and real hope: How new research is changing cancer care
When survival statistics shift this dramatically, it signals more than progress; it marks a turning point in how ...
UPPSALA, SE / ACCESS Newswire / March 18, 2026 /Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Biovica, a leader in blood-based biomarkers for cancer treatment monitoring, today ...
IRVING, Texas, Jan. 28, 2026 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, has published a study in ...
Erratum: Estimated Glomerular Filtration Rate Equations Overestimate Renal Function Compared With Measured Glomerular Filtration Rate Using 24-Hour Urine Creatinine Clearance Retrospective, ...
Spencer Laird was diagnosed with colon cancer at 26. At 30, he was told it had returned and spread to his lungs, with one ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results